secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK:        0001048477
Form:       8-K
Filed at:   2025-03-03T23:59:59+00:00
Accession:  0001193125-25-044103
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioMarin amends bylaws to adopt majority voting for directors and tighten advance notice provisions
--------------------------------------------------------------------------------

- Uncontested director elections now require 'for' votes to exceed 'against' votes (majority voting standard).
- Advance notice deadlines clarified; stockholder must appear at meeting or proposal is disregarded.
- Stockholders must update disclosure information as of record date and 10 days before meeting.
- Company may request information on nominee independence; substitute nominees require full disclosure.
- Officers may be removed by majority of directors present at a meeting with a quorum.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1048477/000119312525044103/0001193125-25-044103-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1048477/000119312525044103/d38831d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-044103

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer